Other Clinical Trial - Efficacy Study for Geko Device in VLU Patients

Status Completed

Clinical Trial Summary

Eight weeks, comprised of four weeks Run-in Phase of Standard Care (SC) treatment followed by four weeks of treatment allocated by randomisation (Treatment Phase). To compare two daily geko™ device treatment durations, six hours and 12 hours, in conjunction with SC, with each other and to SC alone, in patients with venous leg ulcers

Clinical Trial Description

1. Screen patient database to identify eligible patients 2. Obtain informed consent and inform participant's GP 3. Complete CRF throughout the study period (demographics, vital signs, medical history, study ulcer history, concomitant medication) 4. Physical examination at the study start up visit and at consecutive weekly visits 5. Take a digital image of the wound at participants weekly visits 6. Assess and report adverse events 7. Apply standard care (compression bandaging) at weekly visits and record all the dressing usage 8. Perform randomisation at the end of week 4 and allocate participant to one of the three treatment groups. 9. Train the participant to use gekoTM devices 10. Schedule weekly visits ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03396731
Study type	Interventional
Source	Firstkind Ltd
Contact
Status	Completed
Phase	N/A
Start date	April 24, 2018
Completion date	August 9, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03903692` - A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers	N/A
Completed	`NCT03257254` - Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
Recruiting	`NCT03666754` - Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer	N/A
Withdrawn	`NCT02912858` - Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients	N/A
Completed	`NCT02482038` - Geko Venous Leg Ulcer Study	N/A
Completed	`NCT02652572` - Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers	Phase 1
Unknown status	`NCT01658618` - Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer	N/A
Completed	`NCT05646121` - Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Completed	`NCT03077165` - Dose-response Relationship Study of S42909 on Leg Ulcer Healing	Phase 2
Completed	`NCT04461132` - The Effect of Manual Lymphatic Drainage	N/A
Completed	`NCT05974982` - Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers	Phase 1
Completed	`NCT04011371` - Cyanoacrylate Closure for Treatment of Venous Leg Ulcers	N/A
Not yet recruiting	`NCT03543007` - Evaluating the Safety and Efficacy of GrafixPL™PRIME for the Treatment of Chronic Venous Leg Ulcers	N/A
Completed	`NCT03286140` - Early Venous Reflux Ablation Ulcer Trial	N/A
Recruiting	`NCT05588583` - A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.	N/A
Not yet recruiting	`NCT04613687` - Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM)	N/A
Recruiting	`NCT05549609` - A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers	Phase 1/Phase 2
Recruiting	`NCT05409976` - The GORE® VIAFORT Vascular Stent IVC Study	N/A
Not yet recruiting	`NCT05089890` - Clinical Investigation of Sorbact® Dressings	N/A
Not yet recruiting	`NCT03670329` - Management of Infection Risk in Non-comparative Trial (MINT)	N/A